Business Wire · Apr 2026
Official launch of InSight Wireless Reader; highlights Wi‑Fi connectivity, four-hormone measurement, HSA/FSA eligibility, and Android support.
Enabling better self care with at-home hormone tracking.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Inito is a privately held at-home diagnostics company focused first on fertility hormone tracking and now expanding into broader home-based hormone diagnostics. Its flagship product measures four hormones at home and uses software/AI to predict fertile days, confirm ovulation, and surface personalized cycle insights.
Primary product
At-home fertility monitor / hormone tracker (Inito Fertility Monitor / InSight Wireless Reader)
Founded
2015
Headquarters
Houston, Texas, United States
Team size
200-300
Industry
Wellness and Fitness Services
Sub-industry
Fertility tech / at-home hormone diagnostics
Offices
Bengaluru, Karnataka, India
Houston, Texas, United States
San Francisco, California, United States
Dubai, United Arab Emirates
London, United Kingdom
Business model
Direct-to-consumer diagnostic device sales
Recurring fertility strip consumables
Consumer health app/software
Funding
Stage
Series B
Total raised
$45M
Latest round
Series B · Dec 2025
Latest amount
$29M
Dec 2025 · Bertelsmann India Investments
Nov 2023 · Fireside Ventures
Mar 2019 · Y Combinator
Jan 2016 · Mecheri Smart Capital
Dec 2014 · Mecheri Smart Capital
People & investors
Leadership
Co-Founder & CEO
Co-Founder & CTO
VP, Head of Marketing
Finance Head
Head of Growth
Engineering Lead
Senior Staff Engineer (Head of Embedded Platforms)
Lead Research and Development Scientist
Work & culture
Public pages emphasize an interdisciplinary, high-ownership culture with open-door communication, collaboration across hardware/software/biotech, user feedback loops, and an explicit focus on work-life balance and wellness.
Compensation
No public salary bands or compensation ranges were found in the sources reviewed.
Product & market
Pricing
Direct-to-consumer starter kit with recurring fertility strip refills/consumables.
Differentiators
- —Measures four hormones, not just LH
- —Confirms ovulation with PdG rather than only predicting a fertile window
- —Uses patented Spectral Mapping technology with independent hormone tracks
- —Combines fluorescence and visual colorimetric sensing
- —Provides numerical hormone values and personalized insights rather than binary results
Technology
React Native
React
Kotlin
Java
JavaScript
TypeScript
Docker
Kubernetes
Terraform
Jenkins
GitHub Actions
PostgreSQL
MongoDB
MySQL
RabbitMQ
SendGrid
Amplitude
BrowserStack
Appium
Selenium
Customers
Couples trying to conceive
People tracking fertility hormones at home
Women seeking ovulation confirmation
Users with irregular cycles or PCOS-like patterns
People preparing for IVF or broader hormone monitoring
Competitors
Mira
Ava
Glow
Clearblue ovulation tests
Traditional LH-only ovulation predictor kits
Scale & contact
Estimated revenue
$1M-$10M
Latest news
Femtech Insider · Apr 2026
Reports the new reader launch and explains the differentiators versus LH-only ovulation tests.
Inito blog · Dec 2025
Company press release announcing the Series B, total equity funding of $45M, and expansion into broader at-home diagnostics.
YourStory · Dec 2025
Summarizes the round, investors, and expansion plans into additional diagnostics beyond fertility.
TechCrunch · Dec 2025
Coverage of the Series B and Inito’s roadmap beyond fertility into broader hormone and at-home health testing.
Jobs and careers at Inito
0 jobs at Inito
No open positions
Check back later for new openings